Skip to main content
Evidence-led patent and technology research

Danisco USA Inc. Granted Patent for FILAMENTOUS FUNGI

The historical GIPResearch article associates Danisco US Inc. with Indian application 10457/DELNP/2012 , titled Filamentous Fungi Having an Altered Viscosity Phenotype , and reports granted patent number 343599 .

Save or follow this source
These actions open third-party AI services. Saving, citation, and future recall are not guaranteed.
Illustrative technology and patent research theme accompanying Danisco USA Inc. Granted Patent for FILAMENTOUS FUNGI
Research focusIdentify the Danisco patent record precisely

Understand the main question and its precise technical or legal scope.

Evidence methodReconstruct the application family and chronology

Evaluate documentary evidence and distinguish current records from assumptions.

Decision supportCreate a comparative biotechnology patent dossier

Connect findings to decisions while identifying limitations and required verification.

Substantive research and evidence

Danisco USA Inc. Granted Patent for FILAMENTOUS FUNGI — research analysis

Identify the Danisco patent record precisely

The historical GIPResearch article associates Danisco US Inc. with Indian application 10457/DELNP/2012, titled Filamentous Fungi Having an Altered Viscosity Phenotype, and reports granted patent number 343599. Importantly, an Indian Patent Office journal published on 5 September 2014 independently identifies the application, title and Danisco US Inc. as the named applicant. That journal also records filing on 30 November 2012, an earlier US priority claim dated 25 August 2010 and an international application identified as PCT/US2011/049164. This confirms the identity of the published application, not its current enforceability. The 343599 grant number and its legal status need a separate check against the official Indian patent register and file wrapper before any current legal conclusion is made.

Source for this point: IP India — Patent Office Journal 5 September 2014, Danisco 10457/DELNP/2012 (Indian application publication indexed; direct PDF fetch requires recheck).

What technical problem did the application address?

Filamentous fungi are used to manufacture industrial proteins, including enzymes, in submerged fermentation. Physical growth behavior affects reactor mixing, oxygen transfer, flow properties and downstream processing. The publication describes variant filamentous fungi with altered growth characteristics, intended to improve suitability for large-scale production. The central research question is whether the claimed change alters cultivation behavior or process viscosity in a defined, reproducible way, rather than merely identifying a strain with a different appearance. Analysts should examine the description's experimental controls, morphological measurements, culture conditions and comparisons with parent strains. A technical advantage under one fermenter condition should not automatically be treated as established across species, industrial scales or protein products.

Illustrative evidence-mapping research diagram for Danisco USA Inc. Granted Patent for FILAMENTOUS FUNGI
Research illustration — a conceptual framework, not a reproduction of an actual patent record.

Distinguish disclosed concepts from claim boundaries

An abstract may describe altered viscosity and commercial enzyme production broadly, but infringement and patentability questions turn on the actual claims in the relevant jurisdiction. The first claim review should identify whether protection is requested for an organism, genetic modification, culture method, fermenter process, or resulting product. Subsequent claims may depend on a host species, gene modification, morphology, broth condition or measurable phenotype. Record every quantitative limitation and cross-check it with examples. A claim map should separate mandatory elements from optional embodiments, and it should identify whether amendments narrowed the original filing during examination. The Indian and international versions must be compared explicitly; an international publication does not establish the content of the final Indian grant.

Reconstruct the application family and chronology

The 2014 Indian publication identifies international publication WO2012027580 and the associated PCT application. Family analysis begins by recording the priority document, publication dates, national phase entries and legal events in each relevant country. This prevents a common error: counting related national publications as independent technological inventions. Review the EPO and WIPO records for family links, then confirm national events with the authority responsible for each right. A family chart should show applicant names as recorded at different dates, because an original applicant, current proprietor and licensing operator are not always the same entity. The current assignment chain cannot be inferred solely from an old article or a patent-data aggregator's assignee field.

Source for this point: Google Patents — WO2012027580A1 Danisco international application (Published international application; not evidence of current Indian grant status).

Examine biological enablement and deposit requirements

If the claimed fungal variant cannot be reproduced adequately from its written description, a biological deposit may be relevant. The Budapest Treaty permits internationally recognized deposits for specified patent-disclosure purposes, but it does not replace all descriptive requirements. Check whether a deposit identifier, sequence, host background, transformation method and relevant strain characteristics appear in the actual filing. Also review reproducibility of the viscosity phenotype: culture age, fermentation medium, temperature, shear conditions, sample preparation and measurement protocol can change reported behavior. An effective research table connects each biological feature to the particular disclosure or deposited material supporting it. The absence of a required source or deposit is a legal analysis issue, not evidence that a patent is automatically invalid.

Source for this point: WIPO — Budapest Treaty summary (Official treaty guidance).

Treat examination objections as a procedural history

The legacy WordPress article says that the Indian examiner raised an objection under section 3(d), and that the applicant distinguished the claimed fungi from known substances. This is a useful lead, but it is not a verified reproduction of the complete official prosecution record. Retrieve the first examination report, applicant responses, hearing submissions if any and final amended claims. Note which arguments were accepted, which were withdrawn and whether the grant followed amendments. India's sections 3(c), 3(d) and other relevant provisions require claim-specific analysis: an engineered biological invention is not resolved by the observation that it concerns a living organism. The published grant, opposition history and current maintenance status require separate documentary confirmation.

Create a comparative biotechnology patent dossier

A useful original output is a claim-to-technical-effect matrix. Its rows could include hyphal morphology, broth flow behavior, enzyme recovery and culture reproducibility, with columns for claimed feature, cited evidence, control condition and unresolved limitation. A second comparison should examine earlier filamentous-fungi documents using genetic approaches, fermentation optimization or altered growth patterns. Use a clearly defined sampling method rather than assuming all publications with the same organism name are competing patents. Citation analysis should identify whether a later document cites this family for background, a technical teaching or an examiner rejection. Raw forward-citation counts alone do not establish scientific or commercial importance.

What can be concluded at this stage?

There is a verified Indian publication identity for the Danisco application and a credible international family trail. The historical site reports the Indian grant and identifies the claimed area as altered-viscosity filamentous fungi. The following remain unverified for current publication: exact final Indian independent claims, complete examiner treatment, current proprietor, renewal status, any litigation or opposition, and whether any particular industrial process falls within the claim language. The dossier should report those as open fields rather than treating the original headline as proof of an active exclusive right. A client-specific assessment would require the complete register, patent documents and a defined target technology or fermentation process.

The independent publication evidence establishes an application event in 2014; it does not authenticate the historical website's statement about the final Indian patent number or the current patent register. These should be separate evidence rows with different verification states. Similarly, genetic and fermentation descriptions in a family publication may be broader than the issued Indian claims. Any technical comparison should identify whether it uses a published application, amended claims, an experimental example or a live commercial process, because their evidentiary meanings differ. Before making a business recommendation, obtain updated legal-status records and verify the applicable claims in the country of use. Until then, commercial conclusions about blocking rights, licensing leverage or freedom to operate remain conditional and should not be presented as verified findings.

Original evidence-to-decision matrix

Research dimension Evidence to inspect Interpretation boundary
Patent identity Indian publication 10457/DELNP/2012 Final grant claims and current register status needed
Fermentation phenotype Original experimental broth tests Operating conditions and comparators need inspection
Family and ownership WO2012027580; priority documents Recorded assignee changes not verified for India

Research readiness checklist

  • Obtain the final Indian claims for reported grant 343599.
  • Compare the 2014 publication and WO family text.
  • Find the actual FER and applicant reply.
  • Verify legal status and current proprietor directly.

References and primary sources

  1. IP India — Patent Office Journal 5 September 2014, Danisco 10457/DELNP/2012. Indian application publication indexed; direct PDF fetch requires recheck.
  2. Google Patents — WO2012027580A1 Danisco international application. Published international application; not evidence of current Indian grant status.
  3. WIPO — Budapest Treaty summary. Official treaty guidance.
  4. GIPResearch.com — preserved Danisco historical article. Original site assertion; not independent patent-office verification.

General research only. Any current grant, claim, ownership, legal status or professional opinion requires verification of official records and the facts of the particular matter. Full disclaimer

Featured Work & Insights